Amber M. Yates, MD
Department or Service
- Texas Medical Center
- Sickle Cell Disease
Associate Director, Pediatric Hematology/Oncology Fellowship Program
Associate Professor, Department of Pediatrics, Section of Hematology/Oncology, Baylor College of Medicine
|University of Tennessee College of Medicine||fellowship||Pediatric Hematology Oncology||2010|
|University of Tennessee College of Medicine||residency||Pediatrics||2006|
|Louisiana State University, Health Sciences Center, School of Medicine||medical school||Doctor of Medicine||2003|
|Northeast Louisiana University||bachelors||Bachelor of Science||1999|
Dr. Amber Yates is Associate Director of the Pediatric Hematology-Oncology Fellowship Program and a member of the Hematology Center.
Her primary clinical interest is in the care of children with sickle cell disease and other hemoglobin disorders. She is particularly interested in the role of hydroxyurea therapy in improving the lives of children with sickle cell disease, as well as the long term safety and efficacy of hydroxyurea. Her other clinical interests include: hemoglobinopathies and hemolytic anemia.
Dr. Amber Yates is also interested in assisting teenage patients with hematologic disorders so they can achieve a successful transition to adult care.
American Board of Pediatrics
American Board of Pediatrics – Hematology/Oncology
|American Academy of Pediatrics (AAP)||Member|
|American Academy of Pediatrics (AAP), Hematology-Oncology Executive Committee, Council on Communications and Media||Member|
|American Society of Hematology (ASH)||Member|
|American Society of Pediatric Hematology/Oncology (ASPHO)||Member|
|Texas Pediatric Society||Member|
Dr. Amber Yates' research interests are in sickle cell disease and hydroxyurea therapy.